Holen Sie sich die Stockscreener-App
50.21
0.38%
0.19
Handel nachbörslich:
51.21
1.00
+1.99%
Schlusskurs vom Vortag:
$50.02
Offen:
$49.92
24-Stunden-Volumen:
555.14K
Relative Volume:
0.49
Marktkapitalisierung:
$1.45B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
11.23
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+2.07%
1M Leistung:
+12.55%
6M Leistung:
-33.74%
1J Leistung:
-59.68%
1-Tages-Spanne:
$49.02
$50.39
1-Wochen-Bereich:
$48.21
$52.49
52-Wochen-Spanne:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
50.21 | 1.47B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
UBS Downgrades Inspire Medical Systems to Sell From Neutral, Cuts Price Target to $39 From $67 - marketscreener.com
UBS initiates Inspire Medical stock with Sell rating on growth concerns - Investing.com
INSP|Inspire Medical Systems Inc|Price:50.920|Chg%:+1.730 - TradingKey
Form 4 Inspire Medical Systems Inc For: 27 July By Investing.com - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) awards 5,631 RSUs to board member Carrel - Stock Titan
Inspire Medical Systems, Inc. (INSP) director files initial Form 3 with no holdings - Stock Titan
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
Inspire Medical (2DR) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems adds AtriCure CEO to board - Investing.com
Inspire Medical Systems adds AtriCure CEO to board By Investing.com - Investing.com South Africa
Inspire's New Director Comes From AtriCure, Which Helped Over 1M Patients - Stock Titan
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical (2DR) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical (2DR) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo! Finance Canada
TradingKey - TradingKey
INSP|Inspire Medical Systems Inc|Price:49.750|Chg%:+0.560 - TradingKey
Inspire Medical Systems, Inc. Revenue Breakdown – BOATS:INSP - TradingView
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems (INSP) Refreshes Its Board, Is It Still Below Fair Value? - Sahm
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc.INSP - marketscreener.com
INSP|Inspire Medical Systems Inc|Price:49.190|Chg%:-1.620 - TradingKey
INSP|Inspire Medical Systems Inc|Price:50.760|Chg%:+0.360 - TradingKey
Inspire Medical names AtriCure CEO Michael Carrel to board - Bitget
Inspire Medical board member Tansey to retire July 30 By Investing.com - Investing.com Canada
Inspire Medical board member Tansey to retire July 30 - Investing.com
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors - The Manila Times
Casey Tansey to Retire from Inspire's Board, Effective July 30, 2026 - TradingView
After more than 18 years, Casey Tansey to retire from Inspire board - Stock Titan
Inspire Medical Systems (INSP) Q4 2024 earnings summary - Quartr
Inspire Medical (INSP) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
1 Billion People Suffer From Sleep Apena. The Future of Treatment Is No Longer Just CPAP. - Men's Health
A Look at Inspire Medical Systems Inc (INSP) After 5.3% Gain -- GF Value $215.85 vs Price $53.27 - GuruFocus
Form 4 Inspire Medical Systems Inc For: 20 July By Investing.com - Investing.com Nigeria
3 Medical Device Stocks Giving Investors a Different Healthcare Play - MarketBeat
Here's why you should retain INSP stock in your portfolio for now - MSN
Understanding Momentum Shifts in (INSP) - Stock Traders Daily
Price to earnings forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Enterprise value to EBITDA forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Form 4 Inspire Medical Systems Inc For: 17 July By Investing.com - Investing.com South Africa
Inspire Medical Systems (NYSE: INSP) director receives 581-share stock fee award - Stock Titan
Inspire Medical Systems (INSP) grants director 383 common shares as fees - Stock Titan
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Yahoo Finance
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54 - Moomoo
Inspire Medical (INSP) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
INSP Maintained by Truist Securities -- Price Target Raised to $54 - GuruFocus
Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating - Moomoo
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Potential Amidst Robust Revenue Growth in the Medical Device Sector - DirectorsTalk Interviews
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):